Immunotherapy for Primary Human Brain Tumors - Brain Tumor Research Collaborative

The Brain Tumor Funders’ Collaborative (BTFC invites responses to its current funding initiative focused on understanding the complex dynamics among the constituents comprising the human neuro-immune system, the heterogeneity of the primary brain tumor, and the brain environment.  The BTFC is requesting proposals on the role of the neuro-immune system in the origin and progression of the immune responses in primary human brain tumors with the hope of developing immunotherapies for treatment of these tumors in patients. The initial response to the RFP requires pre-proposals (due Friday, May 11, 2018) describing studies on the complex roles of immune responses in the context of primary brain tumors in pediatric and/or adult human patients.  Details are available here

Application Due Date

Friday, May 11, 2018

Link to External Announcement